Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

89Bio Inc (NQ: ETNB )

9.860 -0.090 (-0.90%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about 89Bio Inc

< Previous 1 2 3 4 5 Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Investors can start off the day with a breakdown of the biggest pre-market stock movers for Tuesday and the news moving those shares! 
Via InvestorPlace
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
  
Via Benzinga
89bio's Pegozafermin Data Shows Improved Liver Fat, Glycemic Control
Via Benzinga
Analysts Are Bullish On 89bio's NASH Data Slated For Early Next Year
Via Benzinga
Analyst Ratings for 89bio
  Within the last quarter, 89bio (NASDAQ:ETNB) has observed the following analyst ratings: 
Via Benzinga
6 Analysts Have This to Say About 89bio
  Analysts have provided the following ratings for 89bio (NASDAQ:ETNB) within the last quarter: 
Via Benzinga
Where 89bio Stands With Analysts
  Analysts have provided the following ratings for 89bio (NASDAQ:ETNB) within the last quarter: 
Via Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
89bio Shares Climb After Concluding Enrolment In Mid-Stage NASH Study
89bio (NASDAQ: ETNB) has completed enrollment in ENLIVEN, the Phase 2b trial of pegozafermin for the treatment of non-alcoholic steatohepatitis (NASH). 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
  
Via Benzinga
Recap: 89bio Q2 Earnings
  89bio (NASDAQ:ETNB) reported its Q2 earnings results on Thursday, August 11, 2022. Here's what investors need to know about the announcement. Earnings 89bio missed estimated earnings by 14.95%,... 
Via Benzinga
The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
89bio Posts Promising Pegozafermin Data For Severe Hypertriglyceridemia
89bio Inc (NASDAQ: ETNB) 
Via Benzinga
Analyst Ratings for 89bio
89bio (NASDAQ:ETNB) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday
Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results. 
Via Benzinga
Expert Ratings for 89bio
Analysts have provided the following ratings for 89bio (NASDAQ:ETNB) within the last quarter: 
Via Benzinga
This Analyst Thinks 89Bio's Pegozafermin Data Has Exceeded Expectations
Via Benzinga
Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session
Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year. 
Via Benzinga
Disney To $125? Here's The Biggest Price Target Changes For Thursday
Stifel cut SMART Global Holdings, Inc. (NASDAQ: SGH) price target from $45 to $32. SMART Global shares fell 13.1% to $17.62 in pre-market trading. 
Via Benzinga
5 Analysts Have This to Say About 89bio
Over the past 3 months, 5 analysts have published their opinion on 89bio (NASDAQ:ETNB) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's... 
Via Benzinga
The Daily Biotech Pulse: Eli Lilly Modifies COVID-19 Treatment Pact, Oyster Point Outlines Restructuring Plan, Icosavax Posts Interim RSV Vaccine Data
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
U.S. Stock Futures Edge Higher; GDP Report In Focus
Pre-open movers 
Via Benzinga
McCormick, General Mills And 3 Stocks To Watch Heading Into Wednesday
Some of the stocks that may grab investor focus today are: 
Via Benzinga
89bio Pulls Back With Market — But Could The Stock Soar 250%?
89bio, Inc (NASDAQ: ETNB) was plunging almost 10% lower on Friday in sympathy with the general market, which saw the S&P 500 plummeting over 2%. 
Via Benzinga
10 Biggest Price Target Changes For Friday
Barclays cut the price target on Avis Budget Group, Inc. (NASDAQ: CAR) from $245 to $223. Avis Budget shares rose 2.3% to $224.98 in pre-market trading. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
10 Biggest Price Target Changes For Thursday
Wells Fargo cut the price target on Ford Motor Company (NYSE: F) from $24 to $12. Ford shares fell 2.8% to $12.47 in pre-market trading. 
Via Benzinga
90 Biggest Movers From Yesterday
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered... 
Via Benzinga
58 Stocks Moving In Thursday's Mid-Day Session
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.